Baidu
map

Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced BRAF-Mutant Melanoma: The DREAMseq Trial-ECOG-ACRIN EA6134

Atkins, MB; Lee, S; Chmielowski, B; Tarhini, AA; Cohen, GI; Truong, TG; Moon, HH; Davar, D; O'Rourke, M; Stephenson, JJ; Curti, BD; Urba, WJ; Brell, JM; Funchain, P; Kendra, KL; Ikeguchi, AP; Jaslowski, A; Bane, CL; Taylor, MA; Bajaj, M; Conry, RM; Ellis, RJ; Logan, TF; Laudi, N; Sosman, JA; Crockett, DG; Pecora, AL; Okazaki, IJ; Reganti, S; Chandra, S; Guild, S; Chen, HLX; Streicher, HZ; Wolchok, JD; Ribas, A; Kirkwood, JM

Atkins, MB (通讯作者),Georgetown Univ, Med Ctr, Georgetown Lombardi Comprehens Canc Ctr, New Res Bldg Suite 501E,3970 Reservoir Rd NW, Washington, DC 20057 USA.

JOURNAL OF CLINICAL ONCOLOGY, 2023; 41 (2): 186

Abstract

PURPOSECombination programmed cell death protein 1/cytotoxic T-cell lymphocyte-4-blockade and dual BRAF/MEK inhibition have each shown significant cli......

Full Text Link


Baidu
map
Baidu
map
Baidu
map